Trial Profile
Evaluation of the LightPath Imaging System and the PET Tracer 68Ga-RM2 in Wide Local Excision (WLE) for Breast Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2023
Price :
$35
*
At a glance
- Drugs Gallium 68 RM2 (Primary)
- Indications Breast cancer; Carcinoma
- Focus Diagnostic use
- 16 Nov 2018 New trial record